Close this search box.

Offer Your Patients the Best Skin Cancer Treatment Options with SRT-100™

December 7, 2015

As a physician, it is up to you to make sure your patients have access to and are making the best choices possible when it comes to treating their skin cancer. To do so, you must be able to present to them a variety of options for treatment and help them choose the best option for their bodies. While you might have several different options to explore with your patients, the odds are that most of them involve cutting into the skin in some way. Whether it involves excision, curettage or Mohs surgery, all of these involve surgery of some sort, which is intimidating for patients wanting the easiest, most painless and efficient way to remove their skin cancer.

Superficial Radio Therapy gives you the opportunity to treat your patients non-surgically. Superficial Radio Therapy is the non-surgical choice in non-melanoma skin cancer treatment options, and it can also be used to remove keloid scarring. This method is safe and effective at treating basal cell and squamous cell carcinoma, and it saves patients from the burdens of cutting, scarring, healing and recovery time that come along with surgery.

Sensus Healthcare offers Superficial Radio Therapy, the non-surgical route of skin cancer treatment options, using the SRT-100™. The SRT-100™ is an alternative to invasive incisions made during surgery that can damage your patients’ healthy tissue and cause more unsightly scarring in their skin. The SRT-100™ delivers a precise, calibrated dose of Superficial Radio Therapy just skin deep, safely eliminating the non-melanoma skin cancer cells.

This revolutionary treatment machine is the perfect choice for physicians wanting to offer your patients a painless way to skin cancer and keloid recovery. If you have patients with health risks that prevent them from surgical skin cancer treatment options, the SRT-100™ gives you a new way to help those patients, with cure rates that compete with surgical treatments. The SRT-100™ destroys skin cancer without collateral damage to healthy skin cells and puts patients at less risk of infection and scarring.

If you are ready to offer your patients a new, non-surgical, painless, fast and efficient treatment option for their basal cell and squamous cell carcinoma and keloid scarring, Superficial Radio Therapy is the treatment to offer. To learn more about the SRT-100™ and how it can help your practice, contact Sensus Healthcare today. We are ready and willing to answer any questions you have and to help you achieve your skin cancer treatment goals.